Article
A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese.
Acta pharmacologica Sinica - 1 Apr 2010
Qin Wen, Zhang Rong, Hu Cheng, Wang Cong-rong, Lu Jing-yi, Yu Wei-hui, Bao Yu-qian, Xiang Kun-san, Jia Wei-ping
Abstract excerpt
AIM: To investigate a potential association between SNP rs10494366 in the neural nitric oxide synthase adaptor protein (NOS1AP) and efficacy of repaglinide (an insulin secretagogue) in newly diagnosed Shanghai Chinese type 2 diabetes patients. METHODS: A total of 104 newly diagnosed type 2 diabetes patients (69 men, 35 women) were recruited and treated with repaglinide for 24 weeks. Anthropometric measurements,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
